These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1372495)

  • 1. Lymphadenectomy in gastric carcinoma. A prospective and prognostic study.
    Jaehne J; Meyer HJ; Maschek H; Geerlings H; Burns E; Pichlmayr R
    Arch Surg; 1992 Mar; 127(3):290-4. PubMed ID: 1372495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
    Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
    Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
    Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
    Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systematic lymphadenectomy in stomach carcinoma--staging and therapy].
    Jähne J; Maschek H; Meyer HJ; Pichlmayr R
    Zentralbl Chir; 1996; 121(2):126-30. PubMed ID: 8868608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
    Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
    Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
    Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
    Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Superextended lymphadenectomy (D4) in the treatment of gastric adenocarcinoma].
    Di Leo A; Pedrazzani C; Bonfiglio M; Borzellino G; Zerman G; Tasselli S; De Manzoni G
    Minerva Chir; 2002 Oct; 57(5):641-7. PubMed ID: 12370665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence.
    Deng J; Liang H; Sun D; Zhang R; Zhan H; Wang X
    Can J Gastroenterol; 2008 Oct; 22(10):835-9. PubMed ID: 18925308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors in resected stomach carcinoma].
    Oertli D; Herzog U; Tondelli P
    Schweiz Med Wochenschr; 1994 Jun; 124(22):945-52. PubMed ID: 7518097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
    Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
    World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer.
    Lee CM; Cho JM; Jang YJ; Park SS; Park SH; Kim SJ; Mok YJ; Kim CS; Kim JH
    Ann Surg Oncol; 2015 Mar; 22(3):765-71. PubMed ID: 25201506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis with adenocarcinoma of the gastric cardia: clinicopathological analysis and indication for D1 dissection.
    Shimada H; Suzuki T; Nakajima K; Hori S; Hayashi H; Takeda A; Arima M; Gunji Y; Koide Y; Ochiai T
    Int Surg; 1999; 84(1):13-7. PubMed ID: 10421011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the number of metastatic lymph nodes in early gastric cancer.
    Gunji Y; Suzuki T; Hori S; Hayashi H; Matsubara H; Shimada H; Ochiai T
    Dig Surg; 2003; 20(2):148-53. PubMed ID: 12686784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nativity, complications, and pathology are determinants of surgical results for gastric cancer.
    Fortner JG; Lauwers GY; Thaler HT; Concepcion R; Friedlander-Klar H; Kher U; Maclean BJ
    Cancer; 1994 Jan; 73(1):8-14. PubMed ID: 8275442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
    Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
    J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the role of nodal ratio as a prognostic factor for gastric cancer nowadays? Comparison with new TNM staging system and analysis according to the number of resected nodes.
    Aurello P; Catracchia V; Petrucciani N; D'Angelo F; Leonardo G; Picchetto A; Antolino L; Magistri P; Terrenato I; Lauro A; Ramacciato G
    Am Surg; 2013 May; 79(5):483-91. PubMed ID: 23635583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of D1 lymphadenectomy as prognostic marker in gastric cancer.
    Diaz de Liaño A; Ciga MA; Oteiza F; Aizcorbe M; Cobo F; Trujillo R; Nuin MA
    Hepatogastroenterology; 2001; 48(39):895-8. PubMed ID: 11462951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.